Japan to produce 90m doses of AstraZeneca COVID-19 vaccine - Nikkei Asia
GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData
After Celgene deal, BMS shoots up pharma market cap rankings -
Disputes leave AstraZeneca boss with chronic vaccine headache | Financial Times
Party Crasher
AstraZeneca approached Czechia with additional vaccine offer – EURACTIV.com
How AztraZeneca is taking the lead as Big Pharma races to produce a COVID-19 vaccine | Fortune
Should AstraZeneca Be Your Next Coronavirus Buy? | The Motley Fool
What are the Best Blue-Chip Stocks to Watch in the UK? | IG UK
Chart: How COVID-19 Vaccines Changed Pharma Company Profits | Statista
The biopharmaceutical anomaly | Nature Biotechnology
Asian countries seek vaccine supplies after India export curbs hit COVAX | Reuters
What we measure - Access to Medicine Foundation
Q1 2021: A Look at Top 25 Biopharma Companies by Market Cap | BioSpace
World's Best-Performing IPO in 2021 Is a Korean Bioscience Firm - BNN Bloomberg
Daiichi Sankyo: Drugmaker roars back to health with cancer success - Nikkei Asia
AstraZeneca Pharma India Ltd: Sebi censures Astrazeneca Pharma's promoter, Elliot Group - The Economic Times
AstraZeneca's Vaccine Testing Stumble Draws Investor Lawsuit - Bloomberg
GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData
Apple's Colossal Market Cap in Context
U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine | Reuters
AstraZeneca Phase I/II Covid-19 vaccine trial unlikely to show solid data
AstraZeneca plc Share Price (AZN) Ordinary US$0.25 | AZN
Drug wars: how AstraZeneca overtook GSK in UK pharma | Financial Times
Covid-19 drug biopharmaceutical companies outperform with market cap growth in 2021 - Clinical Trials Arena
GlobalData names top 25 global pharma companies by market cap
Prospering in the pandemic: the top 100 companies | Financial Times
